Developing oral small molecule therapies for pemphigus, ITP and MS.
Industry: Health Care
First Day Return: +92.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 08/17/2018 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 6.3 |
Deal Size ($mm) | $106 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/13/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $106 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | South San Francisco, CA, United States |
Founded | 2008 |
Employees at IPO | 53 |
Website www.principiabio.com |